Abstract Cells of the hematopoietic system undergo rapid turnover. Each day, humans require the production of about one hundred billion new blood cells for proper function. Hematopoietic stem cells (HSCs) are rare cells that reside in specialized niches and are required throughout life to produce specific progenitor cells that will replenish all blood lineages. There is, however, an incomplete understanding of the molecular and physical properties that regulate HSC migration, homing, engraftment, and maintenance in the niche. Endothelial cells (ECs) are intimately associated with HSCs throughout the life of the stem cell, from the specialized endothelial cells that give rise to HSCs, to the perivascular niche endothelial cells that regulate HSC homeostasis. Recent studies have dissected the unique molecular and physical properties of the endothelial cells in the HSC vascular niche and their role in HSC biology, which may be manipulated to enhance hematopoietic stem cell transplantation therapies.
growth factors, chemokines, and extracellular matrix (ECM) components that regulate HSC maintenance, self-renewal, differentiation, and regeneration after injury [11, [15] [16] [17] . With initial studies suggesting that ECs support multilineage hematopoiesis in vitro [18] [19] [20] [21] , it was subsequently shown that normal function of bone marrow endothelial cells is required for maintaining hematopoiesis in vivo [22] . Deleting cytokine receptor gp130 in ECs and HSCs led to a hypocellular marrow and anemia. The defects could not be attributed to a requirement of gp130 in HSCs as gp130-deficient HSCs were able to reconstitute irradiated wild-type recipients. However, wildtype HSCs could not reconstitute hematopoiesis in gp130-deficient mice. This data demonstrates that niche factors expressed by endothelial cells are important for hematopoiesis Fig. 1 Endothelial cell-HSC interactions during homing and engraftment. During development and transplantation HSCs must home to, and engraft in, the stem cell niche. a Definitive hematopoiesis is initiated when HSCs are specified from hemogenic endothelium in the aortagonad-mesonephros (AGM) region. HSCs bud from the ventral wall of the dorsal aorta, enter circulation, and home to the fetal liver. After extravasating into the fetal niche, ECs remodel around the HSC in a process termed Bendothelial cell cuddling.^HSCs expand in the fetal niche and then home to, and engraft in, the adult niche in the bone marrow. HSCs engraft in complex and specialized niches consisting of multiple specialized cell types. These niches maintain HSCs and regulate their selfrenewal and differentiation into all mature blood lineages. b HSCs undergo a series of stereotyped actions to home towards the niche, all of which depend on endothelial cells-rolling, arrest and firm adhesion, spreading, and extravasation. Rolling is initiated when E-and P-selectin receptors on ECs tether to their ligands on the HSC, serving as a molecular brake to slow HSC migration in circulation. Chemokine CXCL12 then activates VCAM and ICAM adhesion molecules, which promote firm adhesion of HSCs to vascular ECs. Finally, chemokines and adhesion molecules direct polarized migration across the endothelium and result in HSC extravasation in vivo [22] . ECs, along with stromal cells, are an important source of the two main niche factors-stem cell factor (SCF) and chemokine CXCL12 (also known as stromal derived factor-1). Together, stromal cell and EC expression of SCF and CXCL12 promotes HSC maintenance and localization in the perivascular niche [10, 17, 23, 24] . Although stromal cells express these factors at much higher levels, production of SCF and CXCL12 by ECs remains important for adequate niche function. Depleting either SCF or CXCL12 from ECs in the perivascular niche using endothelial specific receptor tyrosine kinase Tie2-Cre depletes stem cells in the bone marrow [17, [23] [24] [25] .
The hematopoietic cell types and genetic pathways that control their regulation are highly conserved through vertebrate evolution [26] . The teleost zebrafish is a unique model for studying hematopoiesis. In zebrafish, hematopoiesis occurs through primitive and definitive waves, orthologues to mammalian transcription factors are expressed and regulate blood development, and large-scale genetic screens have identified zebrafish mutations that model known human diseases [26, 27] . In zebrafish, primitive hematopoiesis takes place in the intermediate cell mass, producing erythroid and myeloid cells [26] . As in mammals, definitive HSCs bud off from the AGM and subsequently migrate to and colonize other niches, where the hematopoietic stem and progenitor cell (HSPC) population expands [28, 29] . The zebrafish fetal niche, analogous to the fetal liver, is a vascularized plexus in the tail, known as the caudal hematopoietic tissue (CHT) [28] . After HSPCs double in the CHT, they migrate to and colonize adult niche sites, the thymus and kidney marrow [28, 29] . The transparency of the zebrafish embryo allows for highresolution time-lapse imaging of unperturbed HSPC birth, migration, proliferation, and engraftment, including complex cell-cell interactions between HSPCs and endothelial cells [7, 8, [28] [29] [30] [31] .
Hematopoietic stem cell-endothelial cell interactions from birth to the niche Hematopoietic stem cells (HSCs) maintain a unique relationship with endothelial cells throughout life. Endothelial cells (ECs) make up the inner cellular lining of blood vessels and lymphatics. Rather than acting as a passive barrier, ECs are metabolically active and play important roles in HSC development, homeostasis, and regeneration [32] . Forming a complex network throughout the body, ECs are important for delivering oxygen and nutrients to tissues, serving as a conduit for blood cell trafficking, and playing a role in innate and adaptive immunity [32] . Far from being a homogenous population of cells, ECs exhibit structural, molecular, and functional heterogeneity between and within organs [32, 33] . The transcriptional regulation and physical properties of the local microenvironment that influence EC specialization are areas of active investigation.
Early in development, endothelial progenitors, or angioblasts, differentiate from the mesoderm. Vessels form de novo from the coalescence of angioblasts in a process known as vasculogenesis [27] . During angiogenesis, the vascular network is elaborated by the sprouting or elongation of existing vessels [27] . Even before the onset of circulation, ECs undergo specialization as the artery and vein are specified. While there are many factors that are expressed differentially between artery and vein ECs, sonic hedgehog, VEGF, and Notch signaling have been shown to be key players in specifying arterial identity [27] . Venous identity is promoted when the transcription factor COUP-TFII cell-autonomously represses Notch and suppresses arterial identity [34, 35] ECs not only make up the inner lining of blood vessels through which HSC traffic but also play an important role in the initial steps of the homing process. ECs both direct HSCs to the bone marrow and function as a molecular brake to slow cell migration under hemodynamic shear stress [42] . Homing receptors facilitate HSC tethering to, and rolling along, the endothelium [43] . Chemokine receptors then activate adhesion molecules and their ligands on stem cells and endothelium to facilitate firm adhesion and allow for endothelial transmigration (Fig. 1b) [42, 43] . HSCs actively enter the bone marrow, migrate through the extravascular space, and lodge in the marrow niche. Engrafted HSCs reside within the bone marrow niche and are able to self-renew and differentiate into all mature blood lineages [44] .
The initial tethering and rolling of HSCs along the blood vessel wall occur under the physiological shear conditions of blood flow and are regulated by adhesion molecules known as selectins [42, 43] . Outside of the bone marrow, E-and Pselectins are upregulated on vascular endothelium to attract leukocytes to sites of injury and inflammation [45] . In contrast, marrow ECs constitutively express selectin, and loss of function studies revealed that homing to the marrow niche is greatly impaired upon E-and P-selectin deficiency [46] [47] [48] . Several selectin ligands are expressed on human CD34
+ HSCs including PSGL-1 (P-selectin glycoprotein ligand-1) and HCELL (hematopoietic cell E-/L-selectin ligand) [49-51], which mediate the rolling and tethering of HSCs along bone marrow vasculature [52, 53] . The transition to firm adhesion is then triggered by CXCL12 [54] , a key chemokine expressed by marrow ECs, which directs HSC homing and migration into the niche [55, 56] . Binding of CXCL12 to the CXCR4 receptor on HSCs activates integrins on the surface of HSCs and converts rolling along the vascular endothelium into a stable shear-resistant arrest [57] . The arrest is established through interactions between integrins VLA-4 and LFA-1, and their receptors expressed on the microvasculature, VCAM-1 and ICAM-1, respectively [47, 52, 57]. Loss of both integrin and selectin signaling further impairs HSC homing [58] . VLA-4 and LFA-1 also mediate transendothelial migration across the endothelium [57, 59, 60] . Once extravasated, HSCs transmigrate through the ECM to engraft in the niche. These studies highlight that ECs are much more than a passive border separating peripheral HSCs from the bone marrow niche. Rather, they play an active and crucial role in engraftment by directing migration to, and polarization across, the vascular endothelium into the niche.
Endothelial cells in the perivascular HSC niche
The bone marrow niche contains multiple types of ECs, which play critical roles in HSC regulation. Here, ECs support HSC proliferation and differentiation, homeostasis, and regeneration through production of angiocrine factors [19] . The majority of HSCs are found less than 10 μM from the endothelium [61] . Distinct types of endothelial cells make up vessels with distinct characteristics, and ongoing research seeks to determine whether and how vessel heterogeneity differentially regulates HSCs (Fig. 2a) . In the perivascular niche, arteries branch into small-diameter arterioles, which control the blood flow into the marrow [62, 63] . Arterioles are well oxygenated and have high blood flow velocity and shear rates. These vessels are surrounded by smooth muscle and express high levels of adhesion and tight junction molecules that lead to low permeability [64] . Arterioles are connected to highly branched sinusoidal microvessels, which form a complex network throughout the bone marrow [63, 65, 66] . The thin walls, discontinuous basement membrane, and fenestrations of sinusoidal vessels increase permeability and allow cells and soluble factors to traffic between blood and the marrow [12, 67, 68] . Sinusoidal vessels are distributed evenly through the bone marrow, making up about 30% of the bone marrow volume, whereas arterioles are a rarer population (about 1%) and preferentially located near the bone [62] .
Differences in vessel integrity, permeability, and oxygenation may create distinct HSC microenvironments (Fig. 2b) . Arteriolar ECs express higher levels of VCAM-1, which has been associated with HSC retention [64, 69, 70] , while sinusoidal ECs express higher levels of E-selectin [64] , which is important for HSC homing and proliferation [71] . While multiple recent studies have reported that quiescent HSCs are localized near arterioles [62, 72, 73] , several others have identified dormant HSC populations close to the sinusoidal endothelium, which is where the vast majority of HSCs reside [14, 61, 62, 74] . Differential vascular permeability between arterioles and sinusoids affects the degree to which HSCs are exposed to blood plasma components and reactive oxygen species (ROS) levels. Arterioles are less permeable and maintain a ROS low environment, whereas leaky sinusoids increase exposure of perivascular HSCs to ROS [64] . High ROS levels promote HSC differentiation, exhaustion, and mobilization rather than maintaining HSC quiescence, self-renewal, and long-term repopulating potential [64, [75] [76] [77] [78] . Recent work reports that arteriolar-associated HSCs have low intracellular ROS levels whereas both ROS low and ROS high HSCs are found near sinusoids [64] . Distinct stromal cells associate with arteriolar and sinusoidal vessels, which may help regulate HSC cycling states [62] . Future research is necessary to investigate whether endothelial subtypes truly create unique microenvironments within the perivascular bone marrow niche that have distinct properties in regulating HSC homeostasis.
Until recently, it has been hard to map out the microvasculature organization and flow due to the technical difficulties of imaging through opaque bone. HSC homing and HSCniche localization have been successfully imaged directly in the perivascular endosteal niche in the calvarium of the skull, a functional site of hematopoiesis [65, 79] . Similar techniques were used to study the effect of blood flow on HSC homing in the unperturbed marrow in a living mouse [80] . These studies showed that while marrow arterioles exhibit flow velocities and shear stress similar to arterioles in other locations, the flow velocity and shear stress of marrow sinusoidal vessels are significantly lower than those in capillaries elsewhere [80] . It is possible that it is this lower shear stress that helps regulate HSC homing to the sinusoidal vessels in the marrow.
Real-time endogenous HSC-niche interactions can be exquisitely imaged in the living transparent zebrafish embryo. Lineage tracing of single cells in zebrafish embryos demonstrated that a bipotential hemangioblast can give rise to both ECs and hematopoietic cells [81] . The birth of definitive HSCs from an endogenous niche was first visualized using non-invasive live imaging in the zebrafish [7, 8] Fig. 2 Endothelial cells regulate HSC engraftment and maintenance in the adult bone marrow niche. The bone marrow niche consists of different types of blood vessels. a The vascular architecture and properties of bone marrow ECs differ between arteriolar and sinusoidal vessels. Arterioles, which have low permeability and high rates of blood flow, branch into sinusoids, which have high permeability and low rates of flow. Differences in arteriolar and vascular associated cells can be observed and may have an impact on the regulation of HSCs within these niches. Non-myelinating Schwann cells that maintain hibernating HSCs exclusively associate with arterioles, whereas megakaryocytes, that also establish a quiescent niche for HSCs localize near sinusoids. b The bone marrow perivascular niche contains numerous cell types including stromal cells, macrophages, megakaryocytes, osteoblasts and osteoclasts, sympathetic nerves, and endothelial cells. Endothelial cells play an important role in HSC maintenance, self-renewal, and differentiation, and are an important source of two key angiocrine factors, CXCL12 and SCF. Distinct subsets of endothelial cells, arterioles and sinusoids, may make up unique bone marrow stem cell niches with different properties. Arteriolar ECs have been associated with HSC retention, whereas sinusoidal ECs release factors that promote HSC proliferation, such as Kit-ligand and Notch ligands. Moreover, sinusoids are the exclusive site of HSC homing and trafficking. The difference in ROS levels between arteriolar and sinusoidal microenvironments may affect HSC cell cycle state and metabolism. Thus far, quiescent HSCs have been observed both near arteriolar and sinusoidal vessels. Nonetheless, the unique physical and molecular properties of the sinusoidal and arteriolar microenvironments may affect HSC state in the ventral wall of the aorta in the AGM bends and is released into the sub-aortic space, where it then transforms into a hematopoietic cell (Fig. 1a) [7] . This study demonstrated that HSCs do not arise from an asymmetric division, but rather from an endothelial to hematopoietic transition. Recent studies have used high-resolution imaging to study the cellular interactions that occur between HSPCs and ECs to form the fetal niche [29] . In unperturbed embryos, Tamplin et al. [29] visualized multiple HSPC-endothelial cell interactions that culminate in HSPC engraftment: HSPCs migrated through circulation to the CHT (the fetal niche), adhered to the endothelial cell wall, extravasated across the vessel, and lodged in the niche. Once lodged, nearby ECs remodeled around the HSPC to form a pocket in a novel behavior termed Bendothelial cell cuddling.^Within this pocket, HSPCs were contacted by ECs, as well as stromal cells and fibroblasts, and underwent cell division. Further, they found that ECs similarly surround HSPCs in dissected mouse E11.5 fetal livers [29] (Fig. 1a) . In mouse, HSCs maintain a close association with ECs in the adult niche [14, 62, 64] . A HoxB5 reporter that labels long-term HSCs (LT-HSC) demonstrated that 94% of LT-HSCs directly adhere to the abluminal surface of ECs in the adult mouse bone marrow [13] . These studies demonstrate the important and diverse roles of ECs in HSC development and engraftment.
It has long been recognized that ECs exhibit dramatic structural heterogeneity between different tissues and organs [82] . Genetic studies have identified the main axes that regulate arterial-venous specification [27, 36] . It is still unknown, however, what factors regulate tissue-specific EC distinctions. Likely, a combination of transcriptional regulation and chemical and physical cues from the microenvironment influence tissue-specific EC identity and specialization. By combining tissue-specific EC purification and microarray profiling, Nolan et al. (2013) identified some of the molecular determinants that belie this diversity. They found that tissue-specific ECs differ by combinatorial expression of transcription factors, angiocrine growth factors, adhesion molecules, and chemokines [33] . Functional analysis of distinct populations of ECs and the molecules they express is hindered by the inability to mark or knockout specific subtypes of ECs, for example by using reporter constructs or Cre drivers. Continued research will uncover markers unique to specific subtypes of endothelial cells in individual tissues, which will help parse apart their specific roles in HSC development and maintenance.
Hematopoietic stem cell transplantation
HSCs are required throughout life to produce specific progenitor cells that will replenish all blood lineages and maintain hematopoietic homeostasis [1] . This balance requires exquisite control, and its disruption can lead to severe disorders and malignancies, such as leukemias and lymphomas [83] .
Hematopoietic stem cell transplantation (HSCT) reconstitutes the blood system of patients who have congenital or acquired disorders of the hematopoietic system or hematologic malignancies [84] . Donor stem cells are injected into the veins of the recipient after which point they must migrate through circulation, exit at the correct location, home to the bone marrow, and engraft in the stem cell niche, a process that mimics normal development [85] . Once in the bone marrow, the transplanted HSCs can differentiate and self-renew to replace the hematopoietic cells of the patient and reconstitute their entire immune system [83] . During this process, patients are severely immunocompromised, which can lead to infection, anemia, or thrombocytopenia, and can increase the risk of transplant-related deaths [83] . Enhancing the processes that underlie homing and engraftment could improve outcomes of transplantation.
Improving homing through ex vivo HSC-endothelial cell co-culture
The first indications that bone marrow endothelial cells regulate HSC function came from the observation that these ECs exhibit adhesive affinity for HSCs and support proliferation and multilineage differentiation of both umbilical cord bloodand peripheral blood-derived HSCs through the release of cytokines [86] . Later co-culture studies with bone marrow sinusoidal ECs revealed that distinct angiocrine factors regulate HSC expansion and differentiation. Self-renewal is stimulated by Kit-ligand and Notch ligands, among others, whereas G-CSF, GM-CSF, IL1, and IL6 direct lineage-specific differentiation [16, 87, 88] . Serum-free co-culture conditions revealed that physiological levels of these angiocrine factors increase self-renewal of HSCs. Interestingly, direct contact between ECs and HSCs is essential for HSC self-renewal and differentiation in culture [16, 87, 88] . This might explain why ex vivo HSC cultures supplemented with only cytokines increases the total number of nucleated cells, but not necessarily the number of long-term engrafting progenitors. As such, it has been proposed that co-culture of HSCs with ECs is necessary to promote ex vivo expansion of HSCs. ECs from the brain, heart, and yolk sac have been shown to enhance expansion of human HSCs in vitro, which are capable of in vivo repopulation in mice and nonhuman primates [89] [90] [91] [92] [93] [94] .
Umbilical cord blood contains ECs that are highly proliferative, and human umbilical vein endothelial cells (HUVECs) can readily be expanded in culture [95] . HUVECs have regularly been used as an in vitro model of the endothelial niche [16, 87, 96] . Several preclinical studies confirmed that co-culturing HSCs in the presence of HUVECs increased progenitor populations and enhanced HSC engraftment and reconstitution in vivo [91, 92, [97] [98] [99] [100] . In fact, HUVECs can be collected from the same cord that provides the cord blood-derived HSCs, eliminating the need to harvest ECs for ex vivo culture by biopsy. These studies illustrate the regulatory effect of ECs on HSCs and may provide an approach for improving HSCT.
Primary adult ECs obtained from bone marrow aspiration are low in number and require growth factor-enriched media for in vitro maintenance. Unfortunately, prolonged culture of bone marrow ECs in the presence of serum leads to loss of angiogenic potential. Growth factor deprivation, however, rapidly induces apoptosis, and therefore, angiocrinecompetent ECs can only be maintained in serum-free conditions for very short periods of time. To address this issue, methods to culture vascular endothelial cells were established that maintain angiogenic state and provascular functions [101, 102] . Activation of Akt-PI3K-mTOR signaling in primary ECs, by introduction of the adenoviral E4ORF gene or constitutively active Akt, promotes survival of ECs in serum-free conditions and induces expression of angiocrine factors that supports expansion of murine HSCs. Co-activation of Akt and MAPK shifts the balance towards differentiation and is associated with pro-differentiation angiocrine factors such as IL6 [16] . These engineered EC-HSC co-cultures promote expansion of human and mouse HSPCs ex vivo and enhanced in vivo long-term multilineage engraftment and reconstitution [16, 87, [102] [103] [104] . E4ORF1 + ECs have been shown to enter a state of replicative senescence and have not demonstrated any malignant potential. A preclinical trial where co-cultured E4ORF1 + EC and HSC were transplanted into irradiated recipients demonstrated enhanced expansion and long-term hematopoietic reconstitution in a nonhuman primate study [105] . This study revealed that E4ORF1 + EC-mediated HSC expansion may be safe and effective in human clinical transplantation and could possibly improve transplant outcomes.
Improving homing through modulation of chemokine and adhesion molecule interactions
Different strategies have been developed to increase homing and engraftment of HSCs upon transplantation. Not surprisingly, much research has focused on the CXCR4/CXCL12 signaling axis. Various studies have sought to prime CXCR4 receptors to CXCL12 gradients. Within the cell membrane, receptors can organize into specific subdomains known as lipid rafts. These domains play an important role in efficient interactions between signaling molecules and their cell surface receptors. Moreover, they orchestrate interactions with downstream effectors of signaling pathways, such as Rho and Rac [106] . Activation of these small GTPases results in cytoskeleton reorganization, an essential event for cell adhesion and migration [107] . Therefore, it was hypothesized that increasing CXCR4 localization in lipid rafts may improve HSCTs. Several ex vivo stimuli enhanced lipid raft formation and improved homing and engraftment efficiency. These stimuli, such as mild heat treatment of HSCs, are now proposed as priming strategies for clinical applications [108] [109] [110] . Homing can also be enhanced by increasing CXCR4 expression on HSCs. Platelet-derived microparticles (PMP) improve homing efficiency through receptor transfer. HSCs can interact with PMPs and incorporate part of the platelet membrane, hereby increasing their CXCR4 expression through receptor transfer [111, 112] . Because transgenic overexpression of CXCR4 may have negative long-term side effects, CXCR4 receptor expression has also been upregulated using small molecules. The small lipid mediator prostaglandin E2 (PGE2) increases CXCR4 expression and engraftment of human HSCs [113] [114] [115] [116] . Ex vivo PGE2 treatment of HSCs exhibited safety and clinical potential in a phase I clinical trial [116] , and a phase 2 trial is ongoing. Additionally, valproic acid, a histone deacetylase inhibitor, increased CXCR4 expression on HSCs and promoted migration towards a CXCL12 gradient [117, 118] . Homing may also be enhanced by preventing inactivation and/or degradation of CXCL12. CD26 is a peptidase expressed on HSCs that can inactivate CXCL12 before it interacts with CXCR4. Inhibition of CD26 increased HSC homing and engraftment in vivo and the CD26 inhibitor DPP-4 is currently in clinical trial for improving umbilical cord blood transplantation [117, 119, 120] .
Several studies have modulated selectin signaling between HSCs and ECs to enhance homing and engraftment. Proper adhesion between selectins and their ligands requires fucosylation of selectin ligands. Ex vivo treatment of human cord blood-derived HSCs with fucosyltransferase successfully improves rolling and engraftment in the bone marrow of sublethally irradiated NOD/SCID mice [121] . Enhancing selectin-mediated adhesion holds great potential for improving umbilical cord blood transplantations. Selectin ligand PSGL-1 is expressed in a non-fucosylated form on cord blood HSCs [53] . As a result, HSC rolling, extravasation, and engraftment along the marrow endothelium are reduced. This could be augmented by fucosyltransferase treatment [121] . Insights gained from the cell-cell interactions and molecular signaling pathways that regulate HSC development, homing, and engraftment can help inform studies to improve HSC expansion and hematopoietic stem cell transplantation.
Conclusion
Hematopoietic stem cells are critical for survival. The cells and signals that regulate HSC production, expansion, homing, engraftment, homeostasis, and regeneration are areas of active research. Improving our understanding of these processes could greatly improve our ability to expand HSCs ex vivo, which could advance HSCT. HSCs have a unique relationship with endothelial cells throughout their life. Recent studies have identified molecular and physical properties of bone marrow perivascular endothelial cells that are critical for HSC maintenance, localization, and regeneration. Continued efforts to further define these cells will improve our understanding of HSC development and transplantation. the adenoviral E4ORF1 gene. P Natl Acad Sci USA 105:19288 
